Biogen gets European approval for postpartum depression treatment
Go back to Biogen gets European approval for postpartum depression treatment| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 184.87 -3.21 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $188.08 | 52 Week High | $333.65 | |||
| Open | $186.25 | 52 Week Low | $223.02 | |||
| Day High | $186.25 | P/E | 23.67 | |||
| Day Low | $181.24 | EPS | $7.81 | |||
| Volume | 772,902 | |||||
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 53.87 -0.4 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.27 | 52 Week High | $26.84 | |||
| Open | $53.43 | 52 Week Low | $9.51 | |||
| Day High | $54.24 | P/E | N/A | |||
| Day Low | $52.27 | EPS | $-2.62 | |||
| Volume | 649,634 | |||||
